Who we are

Infectious diseases such as human immunodeficiency virus (HIV), malaria, tuberculosis (TB), neglected and emerging infectious diseases remain a major cause of death, disability, and ill health in sub-Saharan Africa.

Established in 2021, the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking works deliver new solutions to reduce the burden of infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. 

Who we are

Global Health EDCTP3 is a partnership between the European Commission, representing the European Union, and the EDCTP Association, representing the governments of European and sub-Saharan African countries participating in the partnership.

Our vision

To reduce the individual, social, and economic burden of poverty-related infectious diseases, including the neglected, emerging, and re-emerging infectious diseases, in sub-Saharan Africa.

Our mission

To support global collaborative research, capacity strengthening, and international initiatives to accelerate the development, evaluation, and implementation of interventions to prevent, identify, and treat infectious diseases and emerging/re-emerging infections in sub-Saharan Africa with the overarching goal to reduce overall mortality and morbidity.

Our objectives

Global Health EDCTP3 will:

  • contribute to the reduction of the socioeconomic burden of infectious diseases in sub-Saharan Africa by promoting the development and uptake of new or improved health technologies
  • contribute to the increase of health security in sub-Saharan Africa and globally by strengthening the research- and innovation-based capacities for preparedness and response to control infectious diseases.